Back to News
Market Impact: 0.28
Thursday's ETF Movers: ARKG, SIXA
Source: Nasdaq
Healthcare & BiotechMarket Technicals & Flows
The ARK Genomic Revolution ETF rose about 8.5% in Thursday trading, outperforming other ETFs. Key holdings Absci and Schrodinger gained approximately 18.9% and 17.3%, respectively, driving strong performance in genomics and biotech-linked equities.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately positive
Sentiment Score
0.58
Ticker Sentiment
ABSI0.62
SDGR0.58
More News
- Binance seeks to shore up confidence after record $6.3 billion heist
- Amgen (AMGN) Bets on MariTide to Crack $120 Billion Obesity Market
- BTIG cuts Acumen Pharmaceuticals stock price target to $1 on trial results
- Goldman Sachs has revised rate forecasts on 13 economies in the last month
- Wells Fargo raises Abbvie stock price target to $340 on pipeline
- Wells Fargo raises Regeneron stock price target to $925 on execution